Cargando…
Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis
BACKGROUND: Nonadherence to pharmaceutical antidepressant treatment is common among patients with depression. Digitalized follow-up (ie, self-monitoring systems through mobile apps) has been suggested as an effective adjunct to conventional antidepressant treatment to increase medical adherence, imp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600645/ https://www.ncbi.nlm.nih.gov/pubmed/37819697 http://dx.doi.org/10.2196/48843 |
_version_ | 1785126031764488192 |
---|---|
author | Hamlin, Matilda Holmén, Joacim Wentz, Elisabet Aiff, Harald Ali, Lilas Steingrimsson, Steinn |
author_facet | Hamlin, Matilda Holmén, Joacim Wentz, Elisabet Aiff, Harald Ali, Lilas Steingrimsson, Steinn |
author_sort | Hamlin, Matilda |
collection | PubMed |
description | BACKGROUND: Nonadherence to pharmaceutical antidepressant treatment is common among patients with depression. Digitalized follow-up (ie, self-monitoring systems through mobile apps) has been suggested as an effective adjunct to conventional antidepressant treatment to increase medical adherence, improve symptoms of depression, and reduce health care resource use. OBJECTIVE: The aim of this study was to determine patients’ experience of digitalized follow-up using a mobile app as an adjunct to treatment concurrent with a new prescription, a change of antidepressant, or a dose increase. METHODS: This was a qualitative, descriptive study. Patients at 2 psychiatric outpatient clinics were recruited at the time of changing antidepressant medication. After using a mobile app (either a commercial app or a public app) for 4-6 weeks with daily registrations of active data, such as medical intake and questions concerning general mental health status, individual semistructured interviews were conducted. Recorded data were transcribed and then analyzed using content analysis. RESULTS: In total, 13 patients completed the study. The mean age was 35 (range 20-67) years, 8 (61.5%) were female, and all reported high digital literacy. Overall, the emerging themes indicated that the patients found the digital app to be a valuable adjunct to antidepressant treatment but with potential for improvement. Both user adherence and medical adherence were positively affected by a daily reminder and the app’s ease of use. User adherence was negatively affected by the severity of depression. The positive experience of visually presented data as graphs was a key finding, which was beneficial for self-awareness, the patient-physician relationship, and user adherence. Finally, the patients had mixed reactions to the app’s content and requested tailored content. CONCLUSIONS: The patients identified several factors addressing both medical adherence and user adherence to a digital app when using it for digitalized follow-up concurrent with the critical time related to changes in antidepressant medication. The findings highlight the need for rigorous evidence-based empirical studies to generate sustainable research results. |
format | Online Article Text |
id | pubmed-10600645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-106006452023-10-27 Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis Hamlin, Matilda Holmén, Joacim Wentz, Elisabet Aiff, Harald Ali, Lilas Steingrimsson, Steinn JMIR Ment Health Original Paper BACKGROUND: Nonadherence to pharmaceutical antidepressant treatment is common among patients with depression. Digitalized follow-up (ie, self-monitoring systems through mobile apps) has been suggested as an effective adjunct to conventional antidepressant treatment to increase medical adherence, improve symptoms of depression, and reduce health care resource use. OBJECTIVE: The aim of this study was to determine patients’ experience of digitalized follow-up using a mobile app as an adjunct to treatment concurrent with a new prescription, a change of antidepressant, or a dose increase. METHODS: This was a qualitative, descriptive study. Patients at 2 psychiatric outpatient clinics were recruited at the time of changing antidepressant medication. After using a mobile app (either a commercial app or a public app) for 4-6 weeks with daily registrations of active data, such as medical intake and questions concerning general mental health status, individual semistructured interviews were conducted. Recorded data were transcribed and then analyzed using content analysis. RESULTS: In total, 13 patients completed the study. The mean age was 35 (range 20-67) years, 8 (61.5%) were female, and all reported high digital literacy. Overall, the emerging themes indicated that the patients found the digital app to be a valuable adjunct to antidepressant treatment but with potential for improvement. Both user adherence and medical adherence were positively affected by a daily reminder and the app’s ease of use. User adherence was negatively affected by the severity of depression. The positive experience of visually presented data as graphs was a key finding, which was beneficial for self-awareness, the patient-physician relationship, and user adherence. Finally, the patients had mixed reactions to the app’s content and requested tailored content. CONCLUSIONS: The patients identified several factors addressing both medical adherence and user adherence to a digital app when using it for digitalized follow-up concurrent with the critical time related to changes in antidepressant medication. The findings highlight the need for rigorous evidence-based empirical studies to generate sustainable research results. JMIR Publications 2023-10-11 /pmc/articles/PMC10600645/ /pubmed/37819697 http://dx.doi.org/10.2196/48843 Text en ©Matilda Hamlin, Joacim Holmén, Elisabet Wentz, Harald Aiff, Lilas Ali, Steinn Steingrimsson. Originally published in JMIR Mental Health (https://mental.jmir.org), 11.10.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Mental Health, is properly cited. The complete bibliographic information, a link to the original publication on https://mental.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Hamlin, Matilda Holmén, Joacim Wentz, Elisabet Aiff, Harald Ali, Lilas Steingrimsson, Steinn Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis |
title | Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis |
title_full | Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis |
title_fullStr | Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis |
title_full_unstemmed | Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis |
title_short | Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis |
title_sort | patient experience of digitalized follow-up of antidepressant treatment in psychiatric outpatient care: qualitative analysis |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600645/ https://www.ncbi.nlm.nih.gov/pubmed/37819697 http://dx.doi.org/10.2196/48843 |
work_keys_str_mv | AT hamlinmatilda patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis AT holmenjoacim patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis AT wentzelisabet patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis AT aiffharald patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis AT alililas patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis AT steingrimssonsteinn patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis |